The activity of erythromycin against 317 strains of anaerobic bacteria, including 133 strains of the Bacteroides fragilis group, was tested by the agar dilution method in an anaerobic atmosphere with two different concentrations of carbon dioxide and without C02. The effect of the atmosphere of incubation on the agar surface pH was also determined. All strains grew well in the GasPak (GP) environment. However, 3.5 and 30.3% of strains failed to grow in the 2 and 0% C02 environments, respectively. The quality of growth was best in the GP environment and poorest in the 0% C02 environment. Minimal inhibitory concentrations in the GP and 2% C02 environments were frequently the same or one dilution lower in the 0% than in the GP environment. In the 0% C02 atmosphere, minimal inhibitory concentrations were usually two to three dilutions lower than in the GP environment. Consequently, only 24% of B. fragilis strains were susceptible to erythromycin in the GP environment, whereas 77% were susceptible in the 0% C02 environment. For Fusobacterium species, 12% were susceptible to erythromycin in the GP environment, and 73% were susceptible in the 0% C02 environment. There was a comparable decrease in pH in all three atmospheres tested. In vitro susceptibility testing of erythromycin against anaerobic bacteria should be performed in an atmosphere containing carbon dioxide.
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Numerous variables affect the results of susceptibility testing of anaerobic bacteria. Differences due to such factors as the pH of the medium and the presence and amount of C02 in the atmosphere of incubation remain to be fully defined. Data from several laboratories show considerable variation in the susceptibility of anaerobic bacteria to erythromycin (1, 5, 6, 16, 17) . Significant differences in the antibacterial activity of erythromycin against Bacteroides fragilis have been reported to be due to the pH of the medium employed and the presence or absence of C02 in the atmosphere of incubation (3, 5, 14) .
Consequently, we tested the activity of erythromycin against 317 anaerobic bacteria, including 133 strains of the B. fragilis group, in three anaerobic atmospheres with different concentrations of carbon dioxide. The surface pH of uninoculated plates and plates inoculated with test strains in the three atmospheres of incubation was also determined. 
MATERIALS AND METHODS
The activity of erythromycin was tested against 317 strains of anaerobic bacteria, including 133 H2, and 88% N2 (2% CO2), and (iii) 10% H2 and 90% N2 (0% C02).
The 2 and 0% CO2 atmospheres of incubation were obtained by introduction of a gas mixture containing the stated gas concentrations from specially compounded tanks of compressed gas (15) . Air was removed from sealed GP jars by drawing a vacuum of 25 in. (ca. 63.5 cm) of Hg and replaced by the compressed gas. This process was repeated five times. The C02 concentrations of all three environments were measured as follows. Samples (1 ml each) were obtained by withdrawing gas with a specially designed gas sampling device as previously described (15) . The ment showed a decrease in pH of 0.3 in the first 6 h and of 0.3 to 0.5 in 18 to 24 h. Results were similar for the 2% C02 environment. In 0% C02, the decrease in pH was 0.1 to 0.2 in 6 h and also at 18 to 24 and 48 h. The inoculated plates showed similar, but slightly greater, decreases in pH in the GP and 2% C02 environments; however, the reference strains B. vulgatus and P. magnus did not grow in the 0% C02 environment.
DISCUSSION
Because carbon dioxide is essential for the growth of some anaerobic bacteria, it is usually included in the atmosphere of incubation of clinical cultures to assure optimal recovery of anaerobes (8, 14, 15) . The National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing has recommended the use ofthe GP or an equivalent environment (-5% C02) as the reference standard for susceptibility testing of anerobic bacteria (9); yet the effect of C02 on in vitro susceptibility testing of anaerobes remains to be fully defined.
Erythromycin is a macrolide antibiotic that is elaborated by Streptomyces erythraeus. Early studies showed the optimal pH for susceptibility testing of erythromycin against Sarcina lutea and streptococci to be between 6.5 and 7.46 (2) . Acid pH was noted to be very destructive to erythromycin, whereas its activity increased with increasing alkalinity, roughly 10-fold for each pH unit (2, 13) . This effect was also noted with the in vitro activity of erythromycin against enterococci (18) and aerobic gram-negative bacilli (7) . The in vivo therapeutic efficacy oferythromycin was reported to be augmented by alkalinization of the urine in patients with urinary tract infections (12, 19) . Rosenblatt and Schoenknecht (10) reported that the addition of C02 to an anaerobic atmosphere of incubation decreased the pH of the medium and the activity of erythromycin against Escherichia coli.
Noting the considerable variations in reported susceptibility results of B. fragilis to erythromycin, Ingham et al. (5) studied the effect of a 10% versus a 0% C02 environment on the susceptibility of 10 strains of B. fragilis, 6 strains of clostridia, and 1 strain each of Haemophilus influenzae, staphylococcus, group A streptococcus, and enterococcus to erythromycin, lincomycin, clindamycin, and rifampin. They noted that the MICs of erythromycin and lincomycin against B. fragilis was 4 to 32 times higher in a 10% C02 environment compared with a 0% C02
enviromment. An alteration of the pH of the culture medium from 7.0 to 6.0 produced a similar reduction in erythromycin activity. Except for one strain of Clostridium tertium and H. influenzae, the activity of erythromycin against the other strains tested was not affected by C02 content, nor did the MICs of clindamycin or rifampin vary. Ingham et al. (5) concluded that the addition of C02 resulted in an increased acidity of the culture medium and was responsible for the differences in the susceptibility of B. fragilis to erythromycin reported by various laboratories.
Several alternative mechanisms have been postulated to explain this phenomenon. The pH may affect either the molecular structure of an antimicrobial agent or the bacterial cell surface (11) . Carbon dioxide may cause stimulation of an altemative bacterial biochemical pathway (5) or may influence partitioning of a component between7 the product and the microbial cell (11 (3, 5) conclude that the variation in susceptibility is due to the marked difference in pH (i.e., acidity) of the culture medium, our results show a comparable decrease in pH in all three atmospheres tested ( Table 2) .
Whereas adjustment of pH to a neutral or slightly alkaline value may decrease some of the variability of testing B. fragilis susceptibility to erythromycin, our data indicate that poor growth of B. fragilis and other anaerobic bacteria in a 0% C02 environment also contributes to increased susceptibility. In accord with other reports (3, 5), we found a dramatic increase in susceptibility of anaerobic bacteria, especially B. fragilis and Fusobacterium species in the 0% C02 environment compared with the GP (5% C02) and 2% C02 environments (Table 1 ). Due to the poorer growth or failure of growth of many anaerobic bacteria in 0 and 2% C02 environments and in accord with the recommendations of the National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing (9), we recommend the use of a GP or equivalent (5% C02) environment for susceptibility testing of anaerobic bacteria.
